APA-referens (7:e uppl.)

Zhang, W., Xiong, J., Li, Y., Nie, J., Zhao, W., Guo, Z., . . . He, Y. (2025). Efficacy and safety of distinct regimens for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors. Therapeutic Advances in Medical Oncology, 17, . https://doi.org/10.1177/17588359251338046

Chicago-referens (17:e uppl.)

Zhang, Wengang, et al. "Efficacy and Safety of Distinct Regimens for Individuals with Advanced EGFR-mutated Non-small-cell Lung Cancer Who Progressed on EGFR Tyrosine-kinase Inhibitors." Therapeutic Advances in Medical Oncology 17 (2025). https://doi.org/10.1177/17588359251338046.

MLA-referens (9:e uppl.)

Zhang, Wengang, et al. "Efficacy and Safety of Distinct Regimens for Individuals with Advanced EGFR-mutated Non-small-cell Lung Cancer Who Progressed on EGFR Tyrosine-kinase Inhibitors." Therapeutic Advances in Medical Oncology, vol. 17, 2025, https://doi.org/10.1177/17588359251338046.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.